Evaluating the Diagnostic Efficacy of 18 F-FDG PET-CT in Conjunction with Ultrasound-Guided Core Needle Biopsy for Primary Gastrointestinal Lymphoma Patients: A Multicenter Analysis - Scorecard - MDSpire
Advertisement
Evaluating the Diagnostic Efficacy of 18 F-FDG PET-CT in Conjunction with Ultrasound-Guided Core Needle Biopsy for Primary Gastrointestinal Lymphoma Patients: A Multicenter Analysis
Clinical Scorecard: Evaluating the Diagnostic Efficacy of 18 F-FDG PET-CT in Conjunction with Ultrasound-Guided Core Needle Biopsy for Primary Gastrointestinal Lymphoma Patients: A Multicenter Analysis
At a Glance
Category
Detail
Condition
Primary Gastrointestinal Lymphoma (PGIL)
Key Mechanisms
Combination of 18 F-FDG PET-CT and ultrasound-guided percutaneous core needle biopsy for accurate diagnosis.
Target Population
Patients with suspected PGIL requiring histopathological confirmation.
Care Setting
Multicenter hospitals with specialized diagnostic facilities.
Key Highlights
PGILs account for 30%-45% of extranodal lymphomas and 5%-20% of non-Hodgkin’s lymphomas.
Ultrasound-guided core needle biopsy is a safe and effective method for diagnosing PGILs.
18 F-FDG PET-CT enhances the accuracy of locating lymphoma lesions for biopsy.
Guideline-Based Recommendations
Diagnosis
Utilize 18 F-FDG PET-CT to identify hypermetabolic lesions.
Confirm PGIL diagnosis through histopathological examination.
Management
Initiate chemotherapy as the primary treatment for PGILs.
Surgical intervention is reserved for cases with complications like perforation or obstruction.
Monitoring & Follow-up
Monitor for complications post-biopsy, such as hemorrhage or infection.
Risks
Surgical resection may increase complication risks and delay chemotherapy.
Patient & Prescribing Data
Histopathologically confirmed PGIL patients treated at Fujian Provincial Hospital and Fujian Medical University Union Hospital.
Minimally invasive biopsy techniques are preferred to avoid unnecessary surgeries.
Clinical Best Practices
Perform coagulation function tests prior to biopsy procedures.
Ensure informed consent is obtained from patients before procedures.
